Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects

References

• HeoYASyedYYRegorafenib: a review in hepatocellular carcinomaDrugs201878995195829915898
   PubMedGoogle Scholar
• XuTZhangJChenWARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transitionCancer Lett2016377214014827126361
   PubMedGoogle Scholar
• HanaokaHNakajimaTSatoKPhotoimmunotherapy of hepatocellular carcinoma-targeting glypican-3 combined with nanosized albumin-bound paclitaxelNanomedicine20151071139114725929570
   PubMed Web of Science ®Google Scholar
• ZhuDWuSHuCFolate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinomaActa Biomater20175839941228627436
   PubMed Web of Science ®Google Scholar
• SabraSAElzoghbyAOSheweitaSASelf-assembled amphiphilic zeinlactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancerEur J Pharm Biopharm201812815616929689288
   PubMed Web of Science ®Google Scholar
• LiJGuoCFengFCo-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacySci Rep2016613878727934917
   PubMedGoogle Scholar
• YangHWangJFanJHIlexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with sorafenib on hepatoma growthToxicol Appl Pharmacol20173159010127986624
   PubMed Web of Science ®Google Scholar
• ZhangCAnTWangDStepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinomaJ Control Release201622619320426896737
   PubMed Web of Science ®Google Scholar
• ZhuJHuMQiuLDrug resistance reversal by combretastatin-A4 phosphate loaded with doxorubicin in polymersomes independent of angiogenesis effectJ Pharm Pharmacol201769784485528425588
   PubMedGoogle Scholar
• di MartinoRMBisiARampaAGobbiSBellutiFRecent progress on curcumin-based therapeutics: a patent review (2012–2016). Part II: curcumin derivatives in cancer and neurodegenerationExpert Opin Ther Pat201727895396528597702
   PubMed Web of Science ®Google Scholar
• ChengYZhaoPWuSCisplatin and curcumin co-loaded nanoliposomes for the treatment of hepatocellular carcinomaInt J Pharm20185451–226127329730175
   PubMed Web of Science ®Google Scholar
• MarquardtJUGomez-QuirozLCamachoALCurcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancerJ Hepatol201563366166925937435
   PubMed Web of Science ®Google Scholar
• LiuYde KeyzerFWangYThe first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: correlation of MRI-microangiography-histopathology in ratsInt J Cancer2018
   Google Scholar
• ZhuJXuXHuMQiuLCo-encapsulation of combretastatin-A4 phosphate and doxorubicin in polymersomes for synergistic therapy of nasopharyngeal epidermal carcinomaJ Biomed Nanotechnol2015116997100626353589
   PubMed Web of Science ®Google Scholar
• YangWJZhouPLiangLNanogel-incorporated injectable hydrogel for synergistic therapy based on sequential local delivery of combretastatin-A4 phosphate (CA4P) and doxorubicin (Dox)ACS Appl Mater Interfaces20181022185601857329767951
   PubMedGoogle Scholar
• BatraHPawarSBahlDCurcumin in combination with anti-cancer drugs: a nanomedicine reviewPharmacol Res20191399110530408575
   PubMed Web of Science ®Google Scholar
• GaoCTangFGongGpH-responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cellsNanoscale2017934125331254228819666
   PubMed Web of Science ®Google Scholar
• XiaoBSiXHanMKCo-delivery of camptothecin and cur-cumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapyJ Mater Chem B20153397724773326617985
   PubMed Web of Science ®Google Scholar
• PinheiroASilvaAMTeixeiraJHExtracellular vesicles: intelligent delivery strategies for therapeutic applicationsJ Control Release2018289566930261205
   PubMedGoogle Scholar
• SeidiKNeubauerHAMorigglRJahanban-EsfahlanRJavaheriTTumor target amplification: implications for nano drug delivery systemsJ Control Release201827514216129454742
   PubMed Web of Science ®Google Scholar
• Zununi VahedSSalehiRDavaranSSharifiSLiposome-based drug co-delivery systems in cancer cellsMat Sci Eng20177113271341
   Google Scholar
• SaleemJWangLChenCCarbon-Based nanomaterials for cancer therapy via targeting tumor microenvironmentAdv Healthc Mater20187201800525
   Google Scholar
• di BucchianicoSGligaARÅkerlundECalcium-dependent cyto- and genotoxicity of nickel metal and nickel oxide nanoparticles in human lung cellsPart Fibre Toxicol20181513230016969
   PubMedGoogle Scholar
• McclementsDJAdvances in nanoparticle and microparticle delivery systems for increasing the dispersibility, stability, and bioactivity of phytochemicalsBiotechnol Adv2018S07349750183013630138
   Google Scholar
• RezaeeMOskueeRKNassirliHMalaekeh-NikoueiBProgress in the development of lipopolyplexes as efficient non-viral gene delivery systemsJ Control Release201623611427317365
   PubMed Web of Science ®Google Scholar
• DaiYXuCSunXNanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironmentChem Soc Rev201746123830385228516983
   PubMed Web of Science ®Google Scholar
• SunYLuJYanDCellular uptake mechanism and clearance kinetics of fluorescence-labeled glycyrrhetinic acid and glycyrrhetinic acid-modified liposome in hepatocellular carcinoma cellsEnviron Toxicol Pharmacol201753465628501784
   PubMedGoogle Scholar
• ZhangJZhengYXieXCleavable multifunctional targeting mixed micelles with sequential pH-triggered Tat peptide activation for improved antihepatocellular carcinoma efficacyMol Pharm201714113644365928994600
   PubMed Web of Science ®Google Scholar
• HanXWangZWangMLiver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administrationDrug Deliv20162351818182926556526
   PubMed Web of Science ®Google Scholar
• SunYDaiCYinMHepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomesInt J Nanomedicine2018131621163229588589
   PubMed Web of Science ®Google Scholar
• WuJLTianGXYuWJpH-responsive hyaluronic acid-based mixed micelles for the Hepatoma-Targeting delivery of doxorubicinInt J Mol Sci201617436427043540
   PubMed Web of Science ®Google Scholar
• D’EsteMEglinDAliniMA systematic analysis of DMTMM vs EDC/NHS for ligation of amines to hyaluronan in waterCarbohydr Polym201410823924624751270
   PubMedGoogle Scholar
• LiZLPengSFChenXPluronics modified liposomes for cur-cumin encapsulation: sustained release, stability and bioaccessibilityFood Res Int201810824625329735054
   PubMed Web of Science ®Google Scholar
• SunDZhouJKZhaoLNovel curcumin liposome modified with hyaluronan targeting CD44 plays an anti-leukemic role in acute myeloid leukemia in vitro and in vivoACS Appl Mater Interfaces2017920168571686828489348
   PubMed Web of Science ®Google Scholar
• JuanjuanMJianmingCNanoformulations of the vascular inhibitors: combretastatin A4 and combretastatin A4 phosphatePharm Scius2016435893898
   Google Scholar
• HongSSThapaRKKimJHRole of zein incorporation on hydrophobic drug-loading capacity and colloidal stability of phospholipid nanoparticlesColloids Surf B Biointerfaces201817151452130096472
   PubMed Web of Science ®Google Scholar
• SuTLongYDengCConstruction of a two-in-one liposomal system (TWOLips) for tumor-targeted combination therapyInt J Pharm20144761–224125225300591
   PubMedGoogle Scholar
• BaghbaniFMoztarzadehFBypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodropletsColloids Surf B Biointerfaces201715313214028235723
   PubMed Web of Science ®Google Scholar
• LiRDengLCaiZLiposomes coated with thiolated chitosan as drug carriers of curcuminMater Sci Eng C201780156164
   PubMed Web of Science ®Google Scholar
• JuLCailinFWenlanWPreparation and properties evaluation of a novel pH-sensitive liposomes based on imidazole-modified cholesterol derivativesInt J Pharm20175181–221321927889588
   PubMedGoogle Scholar
• AlemiARezaJZHaghiralsadatFPaclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacyJ Nanobiotechnology20181612829571289
   PubMed Web of Science ®Google Scholar
• DashTKKonkimallaVBSelection of P-glycoprotein inhibitor and formulation of combinational Nanoformulation containing selected agent curcumin and Dox for reversal of resistance in K562 cellsPharm Res20173481741175028536971
   PubMedGoogle Scholar
• ZhangPLiJGhazwaniMEffective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapyBiomaterials20156710411426210177
   PubMed Web of Science ®Google Scholar
• LvLQiuKYuXAmphiphilic copolymeric micelles for doxorubicin and curcumin co-delivery to reverse multidrug resistance in breast cancerJ Biomed Nanotechnol201612597398527305819
   PubMed Web of Science ®Google Scholar
• ZhangJLiJShiZpH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activitiesActa Biomaterialia20175834936428455219
   PubMed Web of Science ®Google Scholar
• YangZSunNChengRpH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cellsBiomaterials2017147536728930649
   PubMed Web of Science ®Google Scholar
• DeshantriAKMoreiraAVEckerVNanomedicines for the treatment of hematological malignanciesJ Control Release201828719421530165140
   PubMed Web of Science ®Google Scholar
• RenTLinXZhangQEncapsulation of azithromycin ion pair in liposome for enhancing ocular delivery and therapeutic efficacy on dry eyeMol Pharm201815114862487130251864
   PubMed Web of Science ®Google Scholar
• TanJShenWShiWONTD induces growth arrest and apoptosis of human hepatoma BEL-7402 cells though a peroxisome proliferator-activated receptor γ-dependent pathwayToxicol In Vitro201745Pt 1445328834734
   PubMedGoogle Scholar
• FengTWeiYLeeRJZhaoLLiposomal curcumin and its application in cancerInt J Nanomedicine2017126027604428860764
   PubMed Web of Science ®Google Scholar
• HuangDZhangSZhongTMulti-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapyOncotarget2016728436164362827283987
   PubMedGoogle Scholar